🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This trial is a randomized, double-blind, placebo-controlled, crossover stu...
Status
Completed
Location
Maastricht University
Start Date
2016-07-05
Trial ID
NCT02806895
This trial is a randomized, double-blind, placebo-controlled, crossover stu...
Status
Completed
Location
Maastricht University
Start Date
2016-06
Trial ID
NCT02806908
This is a Phase 3 study to assess the long-term safety and maintenance of e...
Status
Completed
Location
Sleep Disorders Center of Alabama
Start Date
2015-05
Trial ID
NCT02348632
Treatments Being Tested
This study is a Phase 3, multi-center, open-label trial to evaluate the lon...
Status
Enrolling By Invitation
Location
Clinical Research Site
Start Date
2026-08-06
Trial ID
NCT07773883
Treatments Being Tested
PARADIGM (Progressing TAAR-1, Dopamine, and Norepinephrine in Depression Us...
Status
Completed
Location
Clinical Research Site
Start Date
2024-03-18
Trial ID
NCT06360419
Treatments Being Tested
Medication is FDA approved. The objective of this project is to test the ef...
Status
Completed
Location
University of Pennsylvania, Behavioral Sleep Medicine Program
Start Date
2023-07-31
Trial ID
NCT05838430
Treatments Being Tested
ENGAGE (Elucidating TAAR-1, Dopamine, and Norepinephrine in Binge Eating Di...
Status
Recruiting
Location
Clinical Research Site
Start Date
2024-04-26
Trial ID
NCT06413433
Treatments Being Tested
The goal of this project is to evaluate the efficacy and tolerability of th...
Status
Unknown
Location
Lindner Center of HOPE
Start Date
2021-06-15
Trial ID
NCT04602936
Treatments Being Tested
This study is a Phase 3, multi-center, randomized, 6-week, double-blind, pl...
Status
Recruiting
Location
Clinical Research Site
Start Date
2026-06-25
Trial ID
NCT07717892
Treatments Being Tested
This trial is a 12 week, randomized, double-blind, placebo controlled, mult...
Status
Completed
Location
Pulmonary Associates
Start Date
2015-05
Trial ID
NCT02348606
Treatments Being Tested